Clinical Trials Browser

INDUSTRY × citarinostat × Thoracic × Clear all

NCT02635061 2024-05-07

Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung